Drug
NT 201
NT 201: highest development phase Phase 2, developed by Merz Aesthetics GmbH. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Merz Aesthetics GmbH
Trials
| Drug | Phase | Indication |
|---|---|---|
| NT 201 NCT05773053 | Phase 2 | Platysma Prominence |
Latest
No recent events.
Follow NT 201 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.